ERBB2 and breast cancer: In one study, tissue microarray data from 334 “mixed” human BCs revealed that Shh expression was higher in the HER2+ subgroup than in other BC subtypes, while Gli1 expression was enhanced in the HER2+ luminal B subtype [28].